Series B Convertible Preferred Stock Purchase Agreement Sample Contracts

Carbon Natural Gas Co – Fifty Thousand Shares of Series B Convertible Preferred Stock PURCHASE AGREEMENT (April 9th, 2018)

This Agreement will confirm the arrangement between Carbon Natural Gas Company, a Delaware corporation (the "Company"), with its principal offices at 1700 Broadway, Suite 1170, Denver, Colorado 80290, and the purchaser whose name and address are set forth on the signature pages hereof (the "Purchaser"), relating to the issuance and sale by the Company to the Purchaser of fifty thousand (50,000) shares of its Series B Convertible Preferred Stock, par value $0.01 per share (the "Preferred Securities") on the terms, conditions and other provisions contained in this Agreement and in the Certificate of Designation (as such term is defined below). In accordance with the terms of the Certificate of Designation of Relative Rights and Preferences of the Series B Convertible Preferred Stock filed with the Delaware Secretary of State (the "Certificate of Designation") on April 5, 2018, the Preferred Securities are convertible into shares of the Company's common stock, par value $0.01 per share (t

Series B Convertible Preferred Stock Purchase Agreement Amendment # 1 (December 2nd, 2016)

This Series B CONVERTIBLE Preferred Stock Purchase Agreement (the "Agreement") Amendment # 1, is made and entered into as of November16, 2016, by and among Oncologix Tech, Inc., a Nevada Corporation (the "Company"), and Diversified Innovative Marketing Enterprise Ltd., a Georgia Corporation, "Purchaser").

Series B Convertible Preferred Stock Purchase Agreement (October 26th, 2016)

This Series B CONVERTIBLE Preferred Stock Purchase Agreement (the "Agreement") is made and entered into as of August 31, 2016, by and among Oncologix Tech, Inc., a Nevada corporation (the "Company"), and Diversified Innovative Marketing Enterprise Ltd., a Georgia Corporation, "Purchaser").

SilverSun Technologies, Inc. – Series B Convertible Preferred Stock Purchase Agreement (August 1st, 2016)

THIS SERIES B PREFERRED STOCK PURCHASE AGREEMENT (the "Agreement"), made as of the last date executed below (the "Effective Date"), by and among SilverSun Technologies, Inc. a Delaware corporation with a principal address of 5 Regent Street, Suite 520, Livingston New Jersey 07039 ("the "Company"), and Mr. Mark Meller, an individual with an address of __________ ("Buyer"). Each of the Company and Buyer is a "Party" and together, are the "Parties."

Collegium Pharmaceutical – COLLEGIUM PHARMACEUTICAL, INC. Series B Convertible Preferred Stock Purchase Agreement Dated as of February10, 2012 (April 2nd, 2015)

This Series B Convertible Preferred Stock Purchase Agreement (Agreement) dated as of February 10, 2012 is entered into by and among Collegium Pharmaceutical, Inc., a Delaware corporation (the Company), and the individuals and entities listed on Schedule A hereto (each a Purchaser and collectively, the Purchasers). In consideration of the mutual promises and covenants contained in this Agreement, the parties hereto agree as follows:

Protext Mobility – Amendment No. 6 to Series B Convertible Preferred Stock Purchase Agreement (May 9th, 2014)
Series B Convertible Preferred Stock Purchase Agreement (March 6th, 2014)

THIS SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this "Agreement") is made as of this 5th day of March, 2014, by and among Transgenomic, Inc., a Delaware corporation (the "Company"), and Third Security Senior Staff 2008 LLC, a Virginia limited liability company ("Senior Staff LLC"), Third Security Staff 2014 LLC, a Virginia limited liability company ("Staff LLC"), and Third Security Incentive 2010 LLC, a Virginia limited liability company ("Incentive LLC" and, together with Senior Staff LLC and Staff LLC, the "Purchasers").

Eos Petro, Inc. – Series B Convertible Preferred Stock Purchase Agreement (May 8th, 2013)

THIS SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the "Agreement") is made and entered into as of the 23rd day of April, 2013, by and among Cellteck, Inc., a Nevada corporation (the "Seller"), and LowCal Industries, LLC, a Wyoming limited liability company ("LowCal") and LowCo [EOS/Petro], LLC, a Wyoming limited liability company ("LowCo," and collectively referred to herein with LowCal as the "Buyers").

Eos Petro, Inc. – Series B Convertible Preferred Stock Purchase Agreement (February 28th, 2013)

THIS SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the "Agreement") is made and entered into as of the 8th day of February, 2013, by and among Cellteck, Inc., a Nevada corporation (the "Seller"), and LowCal Industries, LLC, a Wyoming limited liability company (the "Buyer").

Cancer Genetics, Inc – Amendment and Waiver to Series B Convertible Preferred Stock Purchase Agreement (December 30th, 2011)

This Amendment (this Amendment), dated as of December 8, 2011, by and between Cancer Genetics, Inc., a Delaware corporation (the Company), and (the Purchaser), amends that certain Series B Convertible Preferred Stock Purchase Agreement, by and between the Company and the Purchaser (the Purchase Agreement). To the extent not otherwise defined herein, the capitalized terms used herein shall have the meanings assigned to them in the Purchase Agreement.

Cancer Genetics, Inc – Series B Convertible Preferred Stock Purchase Agreement (December 30th, 2011)

THIS SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the Agreement), dated as of this day of , 2010, by and between Cancer Genetics, Inc., a Delaware corporation (the Company), and the party listed on the Schedule of Purchaser attached hereto as Schedule I (the Purchaser). The Company and the Purchaser are sometimes referred to herein individually, as a Party and collectively, as the Parties.

Poniard Pharmaecuticals, Inc. – Second Amendment to Series B Convertible Preferred Stock Purchase Agreement (September 6th, 2011)

This Second Amendment to Series B Convertible Preferred Stock Purchase Agreement (this Amendment), effective as of the 25th of June, 2009, is entered into by and among Allozyne, Inc., a Delaware corporation (the Company), and the purchasers of the Companys Series B-1 Preferred Stock pursuant to that certain Series B Convertible Preferred Stock Purchase Agreement dated as of the 22nd of October, 2007, as amended by that certain First Amendment to Series B Convertible Preferred Stock Purchase Agreement dated as of the 31st of March, 2009 (collectively, the Purchase Agreement), by and among the Company and each holder of the Companys Series B-1 Preferred Stock (the Purchasers). Capitalized terms used herein that are not otherwise defined herein shall have the meanings given them in the Purchase Agreement.

Poniard Pharmaecuticals, Inc. – Series B Convertible Preferred Stock Purchase Agreement (September 6th, 2011)

THIS SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the Agreement) is made as of the 22nd day of October, 2007 by and among Allozyne, Inc., a Delaware corporation (the Company), and the investors listed on Exhibit A attached to this Agreement (each a Purchaser and together the Purchasers).

Poniard Pharmaecuticals, Inc. – First Amendment to Series B Convertible Preferred Stock Purchase Agreement (September 6th, 2011)

This First Amendment to Series B Convertible Preferred Stock Purchase Agreement (this Amendment), effective as of the 31st of March, 2009, is entered into by and among Allozyne, Inc., a Delaware corporation (the Company), and the purchasers of the Companys Series B-1 Preferred Stock pursuant to that certain Series B Convertible Preferred Stock Purchase Agreement (the Purchase Agreement) dated as of the 22nd of October, 2007, by and among the Company and each holder of the Companys Series B-1 Preferred Stock (the Purchasers). Capitalized terms used herein that are not otherwise defined herein shall have the meanings given them in the Purchase Agreement.

Protext Mobility – Amendment No. 3 to Series B Convertible Preferred Stock Purchase Agreement (March 31st, 2011)

Pursuant to that certain Series B Convertible Preferred Stock Purchase Agreement, dated July 29, 2009, and entered into by and among the Company and Rock Island, as amended by that certain Amendment No. 1 and Amendment No. 2 to the Series B Convertible Preferred Stock Purchase Agreement, dated September 4, 2009 and March 4, 2010, respectively, in addition to any and all other addenda thereto (collectively, the "Agreement"), the Company has agreed to sell to Rock Island or its designees, and Rock Island has agreed to purchase from the Company, an aggregate of 550,055 shares of the Company's Series B Preferred Stock for an aggregate price of $5,000,000. The parties now desire to enter into this Amendment to modify the terms of the Agreement as more specifically set forth herein.

Protext Mobility – Amendment No. 5 to Series B Convertible Preferred Stock Purchase Agreement (November 15th, 2010)

Pursuant to that certain Series B Convertible Preferred Stock Purchase Agreement, dated July 29, 2009, and entered into by and among the Company and the Buyer, as amended by that certain Amendment No. 1, Amendment No. 2, Amendment No. 3 and Amendment No. 4 to the Series B Convertible Preferred Stock Purchase Agreement, dated September 4, 2009, March 4, 2010, May 28, 2010, and July 29, 2010, respectively, in addition to any and all other addenda thereto (collectively the "Agreement"), the Company has agreed to sell to the Buyer or its designees, and the Buyer has agreed to purchase from the Company, an aggregate of 550,055 shares of the Company's Series B Preferred Stock, the Cashless Warrants, the Non-Cashless Warrants and the Additional Shares for an aggregate price of $5,000,000.

Multicell Technologies – Series B Convertible Preferred Stock Purchase Agreement (October 20th, 2010)

This Series B Convertible Preferred Stock Purchase Agreement (this "Agreement") is made as of October 14, 2010, by and among Xenogenics Corporation, a Nevada corporation (the "Company"), and the Multicell Technologies, Inc., a Delaware corporation (the "Purchaser").

CURAXIS PHARMACEUTICAL Corp – Series B Convertible Preferred Stock Purchase Agreement (October 1st, 2010)

This Series B Convertible Preferred Stock Purchase Agreement, dated as of the 30th day of September, 2010 (this "Agreement"), by and between Curaxis Pharmaceutical Corporation, a Nevada corporation (the "Company") and C P Acquisition Partners LP (the "Purchaser"). The Company and the Purchaser are individually referred to herein as a "Party" and collectively, as the "Parties."

Protext Mobility – Amendment No. 4 to Series B Convertible Preferred Stock Purchase Agreement (August 23rd, 2010)

Pursuant to that certain Series B Convertible Preferred Stock Purchase Agreement, dated July 29, 2009, and entered into by and among the Company and Rock Island, as amended by that certain Amendment No. 1, Amendment No. 2 and Amendment No. 3 to the Series B Convertible Preferred Stock Purchase Agreement, dated September 4, 2009, March 4, 2010 and May 28, 2010, respectively, in addition to any and all other addenda thereto (collectively the "Agreement"), the Company has agreed to sell to Rock Island or its designees, and Rock Island has agreed to purchase from the Company, an aggregate of 550,055 shares of the Company's Series B Preferred Stock for an aggregate price of $5,000,000. The parties now desire to enter into this Amendment to modify the terms of the Agreement as more specifically set forth herein.

Protext Mobility – Amendment No. 2 to Series B Convertible Preferred Stock Purchase Agreement (March 31st, 2010)

Pursuant to that certain Series B Convertible Preferred Stock Purchase Agreement, dated July 29, 2009, and entered into by and among the Company and Rock Island, as amended by that certain Amendment No. 1 to the Series B Convertible Preferred Stock Purchase Agreement, dated September 4, 2009, in addition to any and all other addenda thereto (collectively, the "Agreement"), the Company has agreed to sell to Rock Island or its designees, and Rock Island has agreed to purchase from the Company, an aggregate of 550,055 shares of the Company's Series B Preferred Stock for an aggregate price of $5,000,000. The parties now desire to enter into this Amendment to modify the terms of the Agreement as more specifically set forth herein.

ActiveCare – Series B Convertible Preferred Stock Purchase Agreement (March 29th, 2010)
Skypeople Fruit Juice – Series B Convertible Preferred Stock Purchase Agreement by and Among Entech Environmental Technologies, Inc., Barron Partners Lp and Eos Holdings, Llc Dated February 25, 2008 (March 3rd, 2008)

This SECURITIES PURCHASE AGREEMENT (the "Agreement") is made and entered into as of the 25th day of February, 2008 between Entech Environmental Technologies, Inc., a Florida corporation (the "Company"), and each of the parties signatory hereto (each an "Investor", and collectively, the "Investors").

Series B Convertible Preferred Stock Purchase Agreement (October 12th, 2007)

THIS SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this Agreement) is made and entered into as of October 9th, 2007, by and among Nighthawk Systems, Inc., a Nevada corporation, and its subsidiaries, and its subsidiaries (collectively, the Company), and the investors listed on Schedule 1 attached hereto (who shall execute this Agreement and who are collectively referred to as the Investors).

Valentis – Series B Convertible Preferred Stock Purchase Agreement (August 6th, 2007)

This SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the "Agreement") is dated as of July 31, 2007 by and among Urigen Pharmaceuticals, Inc., a Delaware corporation (the "Company"), and each of the Purchasers of shares of Series B Convertible Preferred Stock of the Company whose names are set forth on Exhibit A hereto (individually, a "Purchaser" and collectively, the "Purchasers").

Series B Convertible Preferred Stock Purchase Agreement (February 13th, 2007)

THIS SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this "Agreement") is made and entered into as of January __, 2007 between MPLC, Inc., a corporation organized and existing under the laws of the State of Delaware (the "Company"), and the purchasers listed on Schedule 1 hereto (the "Purchasers").

Ocean Smart, Inc. – SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT Dated as of January 16, 2007 Among EDGEWATER FOODS INTERNATIONAL, INC. And THE PURCHASERS LISTED ON EXHIBIT A (January 17th, 2007)

This SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the Agreement) is dated as of January 16, 2007 by and among Edgewater Foods International, Inc., a Nevada corporation (the Company), and each of the Purchasers of shares of Series B Convertible Preferred Stock of the Company whose names are set forth on Exhibit A hereto (individually, a Purchaser and collectively, the Purchasers).

Dg – Series B Convertible Preferred Stock Purchase Agreement (August 9th, 2005)

WHEREAS, the Company and DG Systems, Inc. (DG) have agreed to enter into (i) a DG and Verance Joint Marketing and Sales Agreement, (ii) a DG and Verance Services Agreement, (iii) a ConfirMedia Data Agreement and (iv) a License Agreement for ConfirMedia Spot Embedding (collectively the Marketing, Operating and Licensing Agreements), each dated as of the date hereof, pursuant to which the Company and DG will, among other things, jointly market the Companys verification and reconciliation services and provide to DG a license to use and market certain of the Companys software, the execution and delivery of which by the Company and DG shall be a condition to the Companys and the Purchasers obligations to consummate the transactions contemplated hereby;

Miravant Med Techs – Series B Convertible Preferred Stock Purchase Agreement (May 6th, 2005)

THIS SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the "Agreement") is entered into as of May 3, 2005, by and between MIRAVANT MEDICAL TECHNOLOGIES, a Delaware corporation (the "Company"), with headquarters located at 336 Bollay Drive, Santa Barbara, California 93117, and the purchasers (collectively, the "Purchasers" and each a "Purchaser") set forth on Schedule 1 hereof, with regard to the following:

Series B Convertible Preferred Stock Purchase Agreement (July 20th, 2004)

This SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the "Agreement") is dated as of July 19, 2004 by and among Home Solutions of America, Inc., a Delaware corporation (the "Company"), and each of the Purchasers of shares of Series B Convertible Preferred Stock of the Company whose names are set forth on Exhibit A hereto (individually, a "Purchaser" and collectively, the "Purchasers").

Prolink Holdings – Contract (May 13th, 2004)

Exhibit 2.6 SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT THIS SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (this "Agreement") is made and entered into as of April 19 2004, between Amalgamated Technologies, Inc, a corporation organized and existing under the laws of the State of Delaware (the "Company"); the purchaser(s) listed on Schedule 1 hereto (the "Purchaser"); and Gottbetter & Partners, LLP, a New York Limited Liability Partnership with an address at 488 Madison Avenue, 12th Floor, New York, NY 10022 (the "Escrow Agent"). WHEREAS, subject to the terms and conditions set forth in this Agreement, the Company desires to issue and sell to the Purchaser and the Purchaser desires to acquire from the Company 100,000 shares of the Company's Series B Preferred Stock, $.0001 par value per share (the "Series B Preferred Stock"), with a Stated Value of one dollar ($1) per share, and an aggregate Stated Value of one h

SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT Dated as of October 31, 2003 Among SATCON TECHNOLOGY CORPORATION and THE PURCHASERS LISTED ON EXHIBIT A (November 13th, 2003)

This SERIES B CONVERTIBLE PREFERRED STOCK PURCHASE AGREEMENT (the Agreement) is dated as of October 31, 2003 by and among SatCon Technology Corporation, a Delaware corporation (the Company), and each of the Purchasers of shares of Series B Convertible Preferred Stock of the Company whose names are set forth on Exhibit A hereto (individually, a Purchaser and collectively, the Purchasers).

Proflowers, Inc. Series B Convertible Preferred Stock Purchase Agreement (September 22nd, 2003)

THIS AGREEMENT is made as of December 29th, 1999, by and between ProFlowers, Inc., a Delaware corporation, with headquarters at 7863 Girard Avenue, Suite 302, La Jolla, California 92037 (the Company), and the investor listed on Schedule 1.2 hereto (the Purchaser). In consideration of mutual promises, covenants and conditions hereinafter set forth, the parties hereby agree as follows: